Skip to main content
Clinical Trials/NCT01449656
NCT01449656
Completed
Not Applicable

A Randomized Trial Comparing the Laryngeal Mask Airway-SupremeTM With the Laryngeal Mask Airway-ProsealTM in Children

Ann & Robert H Lurie Children's Hospital of Chicago1 site in 1 country60 target enrollmentOctober 2011
ConditionsChildren

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Children
Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Enrollment
60
Locations
1
Primary Endpoint
Airway Leak Pressure
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The aim of this randomized prospective study is to compare two laryngeal mask airways with a provision for evacuation of gastric contents, the LMA Proseal and The investigators hypothesize that airway leak pressures with the LMA Proseal will be significantly different (higher) when compared with the LMA Supreme.

Detailed Description

The goal of this study is to compare the LMA Proseal and LMA Supreme in children having surgery. The investigators hypothesize that the airway leak pressures with the LMA Proseal will be superior to the LMA Supreme. Airway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached. The ease of placement of the device and gastric tube, fiberoptic grade of laryngeal view, feasibility of use during positive pressure ventilation, and complications (airway related, gastric insufflation, trauma) will also be assessed.

Registry
clinicaltrials.gov
Start Date
October 2011
End Date
November 2011
Last Updated
14 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Narasimhan Jagannathan

Principal investigator

Ann & Robert H Lurie Children's Hospital of Chicago

Eligibility Criteria

Inclusion Criteria

  • Children undergoing general anesthesia using a supraglottic airway device
  • weight 10-20 kg
  • age 6 months-6 years

Exclusion Criteria

  • ASA class IV, V Emergency procedures
  • History of a difficult airway
  • Active gastrointestinal reflux
  • Active upper respiratory tract infection

Outcomes

Primary Outcomes

Airway Leak Pressure

Time Frame: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours

Airway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached when fresh gas flow is delivered at 3L/min when the pressure limiting valve is closed completely.

Secondary Outcomes

  • Time to secure the airway(participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours)
  • Number of attempts to place the device(participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours)
  • feasibility of positive pressure ventilation(participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours)
  • Ease of gastric tube placement(participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours)
  • Fiberoptic grade of laryngeal view(participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours)
  • Quality of the airway(participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours)
  • Gastric insufflation(participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours)
  • Fiberoptic view through the gastric tube(participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours)
  • Adverse effects(Participants will be followed for the duration of anesthesia and 24 hours postoperatively)

Study Sites (1)

Loading locations...

Similar Trials